Enhanced renoprotective effects of combined glucagon‐like peptide‐1 receptor agonists and sodium‐glucose cotransporter 2 inhibitors in type 2 diabetes mellitus: Real‐world evidence
Dual therapy with GLP-1 RA and SGLT2i is supported to enhance renal outcomes and address the growing burden of diabetic kidney disease.
Authors
- Ming‐Hsien Tsai (ORCID: https://orcid.org/0000-0003-3561-4689)
- Chung‐Yen Huang (ORCID: https://orcid.org/0000-0001-9691-9537)
- Jian‐Yu Jhu
- Mon‐Ting Chen
- Yu‐Wei Fang (ORCID: https://orcid.org/0000-0002-1302-1885)
- Hung‐Hsiang Liou
Institutions
- Fu Jen Catholic University (TW)
- National Taipei University of Nursing and Health Science (TW)
- Jen-Ai Hospital (TW)
- Ministry of Health and Welfare (TW)
Publication Details
- Journal
- Journal of Diabetes Investigation
- Published
- 2024-11-21
- DOI
- https://doi.org/10.1111/jdi.14361
- Citations
- 13
- Primary Topic
- Diabetes Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 4.65
Funders
- Shin Kong Wu Ho-Su Memorial Hospital